Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors
Davies, D.R., Wyatt, K.M., Jardine, J.E., Robertson, I.D. and Irwin, P.J. (2004) Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. Journal of the American Animal Hospital Association, 40 (2). pp. 124-130.
*Subscription may be required
Twenty-seven dogs with inadequately excised, cutaneous mast cell tumors (MCT; 20 residual microscopic disease, seven marginal excision) were treated with a vinblastine and prednisolone chemotherapeutic protocol. Twenty dogs were available for follow-up examination after 12 months. One dog suffered local recurrence of the tumor, four dogs developed new cutaneous tumors, and one dog had both events. Fourteen dogs were free of MCT. There was no confirmed tumor-related mortality. Although toxicity from the chemotherapy was generally mild, one dog died of sepsis during treatment.
|Publication Type:||Journal Article|
|Publisher:||American Animal Hospital Association|
|Copyright:||© 2004 American Animal Hospital Association|
|Item Control Page|